This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Dementia due to Parkinson's disease
PD_DEMENTIA
obsolete_dementia: ['An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.']
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1100 |
4. Check minimum number of eventsNone |
1100 |
5. Include endpointsNone |
1100 |
6. Filter based on genotype QC (FinnGen only) |
965 |
Control definitions (FinnGen only)
- Control exclude
- G6_PARKINSON
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Dementia due to Parkinson's disease
based on the number of shared cases.
Similar with more cases:
- Dementia due to Parkinsons disease, excluding more controls
- Dementia in other diseases classified elsewhere
- Any dementia
- Any dementia, excluding more controls
- Dementia
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 965 | 348 | 617 |
| Unadjusted period prevalence (%) | 0.23 | 0.12 | 0.28 |
| Median age at first event (years) | 76.80 | 77.86 | 76.21 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 992
- Matched controls
- 9920
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N05AH04
ATC
quetiapine; oral
11.0
321.5
501
841
N04BC04
ATC
ropinirole; oral
279.7
307.7
251
12
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3005.6
307.7
953
80
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
307.7
915
*
G20
ICD-10 Finland
Parkinson disease
16185.8
307.7
954
8
N04BC05
ATC
pramipexole; oral
18.7
307.7
444
411
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
307.7
824
*
N04BD01
ATC
selegiline; oral
1006.2
307.7
449
8
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
+∞
307.7
417
*
N87
ICPC
Parkinsonism
580.3
307.7
480
16
N06DA03
ATC
rivastigmine; oral, transdermal
32.3
307.7
572
401
N04BD02
ATC
rasagiline; oral
+∞
275.2
251
*
193
Kela drug reimbursment
Rasagiline
+∞
221.4
204
*
N04BX02
ATC
entacapone; oral
+∞
169.8
158
*
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
41.6
149.5
91
24
N04BB01
ATC
amantadine; oral
31.5
146.8
97
34
R25.1
ICD-10 Finland
Tremor, unspecified
13.6
144.7
143
121
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
140.0
131
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
7.0
127.1
226
403
H02AA02
ATC
fludrocortisone; oral
23.7
121.7
89
41
N03AE01
ATC
clonazepam; systemic
7.5
105.8
167
260
N04AA02
ATC
biperiden; systemic
20.5
89.2
69
36
N04BC09
ATC
rotigotine; transdermal
154.7
81.4
85
6
I95.1
ICD-10 Finland
Orthostatic hypotension
5.5
80.1
175
372
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
+∞
73.9
70
*
R53
ICD-10 Finland
Malaise and fatigue
3.3
72.7
441
1934
G04BD12
ATC
mirabegron; oral
3.8
72.5
290
978
XA800
NOMESCO Finland
Neuropsychological investigation
7.8
62.8
91
127
F0232, G20,
ICD-10 Finland
+∞
58.9
56
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
58.9
436
2086
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.9
57.9
533
2857
N04BX04
ATC
opicapone; oral
+∞
56.8
54
*
F0230, G20,
ICD-10 Finland
+∞
56.8
54
*
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
+∞
54.7
52
*
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
17.0
52.4
44
27
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.3
51.2
148
390
AA1AD
NOMESCO Finland
CT of head and brain
2.7
51.0
503
2740
XF606
NOMESCO Finland
Ortostatic test
15.2
50.5
45
31
A06AD11
ATC
lactulose; oral
2.9
49.1
330
1473
N19
ICPC
Speech disorder
10.0
48.1
56
59
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
10.3
46.6
53
54
A28
ICPC
Limited function/disability NOS
2.6
46.0
397
2001
N04BC06
ATC
cabergoline; oral
126.0
45.2
48
*
R1250
NOMESCO Finland
Evaluation of functional capability
7.3
44.5
67
97
S01.0
ICD-10 Finland
Open wound of scalp
3.4
43.6
179
598
R4130
NOMESCO Finland
Speech therapy
6.4
41.0
70
116
D21
ICPC
Swallowing problem
7.9
40.7
57
76
N29
ICPC
Neurological sympt/complt other
7.4
40.6
60
85
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.1
39.8
88
186
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.1
39.8
71
123
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
109.5
39.0
42
*
L28
ICPC
Limited function/disability (L)
2.5
38.4
354
1810
SPAT1229
SPAT
Assessment of need for aid
3.2
37.3
170
602
N04BC02
ATC
pergolide; oral
359.4
35.2
35
*
R44.1
ICD-10 Finland
Visual hallucinations
13.6
35.0
33
25
S72.0
ICD-10 Finland
Fracture of neck of femur
3.5
33.8
126
393
G02CB01
ATC
bromocriptine; systemic
42.7
33.3
41
10
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
93.4
32.9
36
*
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.4
32.7
67
132
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
+∞
32.5
31
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.5
32.3
121
378
N06AB10
ATC
escitalopram; oral
2.8
32.1
193
794
SPAT1216
SPAT
Assessment of functional ability
2.4
30.6
286
1449
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
29.3
377
2173
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
41.5
29.1
36
9
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
29.0
448
2770
U04
ICPC
Incontinence urine
3.1
28.5
134
480
C07AA05
ATC
propranolol; systemic
2.6
28.1
194
851
N05BA04
ATC
oxazepam; oral
2.2
27.7
326
1806
Z2445
NOMESCO Finland
Psychologist
6.2
27.5
48
81
SPAT1234
SPAT
Support of social functional capacity
3.1
27.4
122
423
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
26.3
250
1265
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
26.0
256
1313
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.7
25.9
153
619
N06AX11
ATC
mirtazapine; oral
2.1
25.9
380
2281
N28
ICPC
Limited function/disability (N)
5.1
25.6
55
113
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.5
25.4
64
150
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
25.3
238
1197
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
25.0
260
1363
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
27.5
23.7
32
12
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
23.0
22
*
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.4
22.5
83
256
W19
ICD-10 Finland
Unspecified fall
2.5
22.4
155
676
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.6
22.1
145
617
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
22.0
21
*
R41.0
ICD-10 Finland
Disorientation, unspecified
3.4
21.5
82
258
F0234, G20,
ICD-10 Finland
+∞
20.9
20
*
N99
ICPC
Neurological disease other
6.3
20.8
35
57
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
20.3
115
454
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
49.1
20.2
24
5
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
6.5
20.2
33
52
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
20.0
248
1377
R5110, ,
SPAT
2.5
19.9
144
640
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.8
19.9
61
166
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
+∞
19.9
19
*
SPAT1172
SPAT
Guidance concerning hydration
3.8
19.7
61
167
F05.9
ICD-10 Finland
Delirium, unspecified
3.9
19.6
59
158
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.9
19.4
35
61
N30.0
ICD-10 Finland
Acute cystitis
2.2
19.4
200
1034
G04BD11
ATC
fesoterodine; oral
3.9
19.0
58
157
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.2
18.9
80
268
R35
ICD-10 Finland
Polyuria
2.6
18.9
122
514
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.3
18.8
164
790
Z75.5
ICD-10 Finland
Holiday relief care
5.7
18.8
35
63
S06.0
ICD-10 Finland
Concussion
2.4
18.0
143
661
S70.0
ICD-10 Finland
Contusion of hip
3.1
18.0
79
271
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
17.2
157
2849
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
35.7
16.7
21
6
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
3.8
16.5
52
144
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
6.6
16.3
26
40
N05AH02
ATC
clozapine; systemic
24.9
16.0
22
9
A04
ICPC
Weakness/tiredness general
2.0
16.0
215
1218
WYA20
NOMESCO Finland
Home visit
3.4
15.4
55
166
N06DA02
ATC
donepezil; oral
2.2
14.8
141
701
SPAT1167
SPAT
Insertion of urinary catheter
2.9
14.7
72
262
G04BD09
ATC
trospium; oral
3.7
14.5
47
133
R55
ICD-10 Finland
Syncope and collapse
2.0
14.3
173
942
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
14.7
14.1
23
16
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
30.5
13.9
18
6
AXX01
NOMESCO Finland
Memory assessment
6.6
13.7
22
34
N05BA06
ATC
lorazepam; systemic, sublingual
2.6
13.7
80
320
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.5
13.6
92
395
F023, G20,
ICD-10 Finland
+∞
13.6
13
*
E86
ICD-10 Finland
Volume depletion
3.1
13.3
56
187
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.1
13.3
57
193
F05.8
ICD-10 Finland
Other delirium
5.8
13.2
24
42
N02AA05
ATC
oxycodone; systemic
1.7
13.1
287
1879
N06AB04
ATC
citalopram; systemic
1.9
13.0
208
1240
SPAT1053
SPAT
Memory test
1.8
12.9
252
1595
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.1
12.6
122
609
R1260
NOMESCO Finland
Evaluation of communicative skills
3.8
12.6
39
107
R23
ICPC
Voice symptom/complaint
4.3
12.5
32
76
Z50.5
ICD-10 Finland
Speech therapy
6.3
12.5
21
34
K59.0
ICD-10 Finland
Constipation
2.4
12.5
91
404
130
Kela drug reimbursment
Malignant tumour
0.2
12.5
16
797
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
12.4
108
517
R32
ICD-10 Finland
Unspecified urinary incontinence
3.3
12.3
47
148
XKD00
NOMESCO Finland
Uroflowmetry
1.7
12.1
255
1648
G25.0
ICD-10 Finland
Essential tremor
3.3
11.8
45
142
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.5
11.7
77
326
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.3
11.5
44
139
N04BX01
ATC
tolcapone; oral
+∞
11.5
11
*
R47.1
ICD-10 Finland
Dysarthria and anarthria
4.5
11.2
27
61
I95.9
ICD-10 Finland
Hypotension, unspecified
3.5
11.2
38
111
F05.1
ICD-10 Finland
Delirium superimposed on dementia
5.1
11.0
23
46
SPAT1254
SPAT
Administration of medicine
1.8
11.0
202
1250
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
4.1
11.0
30
75
N05AH03
ATC
olanzapine; systemic
2.9
10.9
51
181
N05AX08
ATC
risperidone; systemic
2.0
10.9
127
680
N30.9
ICD-10 Finland
Cystitis, unspecified
2.3
10.7
85
391
P20
ICPC
Memory disturbance
1.7
10.7
248
1637
N06AX16
ATC
venlafaxine; oral
2.2
10.7
97
472
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
3.5
10.6
37
110
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.9
10.6
134
738
F22.0
ICD-10 Finland
Delusional disorder
5.1
10.6
22
44
N04BC01
ATC
bromocriptine; oral
111.2
10.4
11
*
F0231, G20,
ICD-10 Finland
+∞
10.4
10
*
A03FA01
ATC
metoclopramide; systemic, rectal
0.5
10.3
75
1524
ICB01, ,
SPAT
10.7
10.3
19
18
N86
ICPC
Multiple sclerosis
23.6
10.3
14
6
NF1AA
NOMESCO Finland
Hip X-ray examination
1.9
10.2
134
746
R2110
NOMESCO Finland
Giving the first information
2.6
10.2
58
229
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
9.8
53
204
UKC02
NOMESCO Finland
Cystoscopy
1.7
9.7
237
1581
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
9.7
85
408
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
9.4
188
1188
S63.1
ICD-10 Finland
Dislocation of finger
4.3
9.4
24
57
N04AA01
ATC
trihexyphenidyl; oral
+∞
9.4
9
*
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
5.2
9.4
19
37
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.1
9.4
39
130
Y94.0
ICD-10 Finland
Accident at home
3.4
9.2
32
95
SPAT1301
SPAT
No procedures
1.6
9.2
338
2479
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
9.2
118
652
S01.9
ICD-10 Finland
Open wound of head, part unspecified
3.6
9.1
30
86
SPAT1125
SPAT
Stoma care and guidance
3.2
9.1
35
111
SPAT1360
SPAT
Extensive global examination
2.1
9.1
85
419
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
9.0
206
1349
J01CA08
ATC
pivmecillinam; oral
1.5
8.8
316
2305
S01
ICD-10 Finland
Open wound of head
4.2
8.7
23
56
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
4.2
8.7
23
56
SPAT1244
SPAT
Occupational therapy
4.9
8.4
18
37
XQ855, ,
SPAT
4.7
8.4
19
41
N04BC07
ATC
apomorphine; parenteral
+∞
8.3
8
*
M48.0
ICD-10 Finland
Spinal stenosis
1.7
8.3
165
1039
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.1
8.3
22
54
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
3.3
8.3
30
92
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.7
8.2
148
906
F06.0
ICD-10 Finland
Organic hallucinosis
14.6
8.2
13
9
R4130, ,
SPAT
14.6
8.2
13
9
H02AB06
ATC
prednisolone; systemic
0.7
8.2
291
3845
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.3
8.1
64
294
R5130, ,
SPAT
9.0
8.1
16
18
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
8.0
83
425
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.1
8.0
*
258
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.0
7.9
89
469
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.1
7.8
*
254
C10AX09
ATC
ezetimibe; oral
0.5
7.8
59
1190
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
7.8
96
523
G21.8
ICD-10 Finland
Other secondary parkinsonism
45.3
7.7
9
*
M04AA01
ATC
allopurinol; systemic
0.5
7.7
76
1400
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.4
7.7
50
1067
J01EA01
ATC
trimethoprim; systemic
1.5
7.6
262
1881
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.6
7.5
43
171
N02BE01
ATC
paracetamol; systemic, rectal
1.7
7.5
849
7737
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.3
7.5
53
233
N06AX26
ATC
vortioxetine; oral
2.5
7.4
47
196
F02.33
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly depression
+∞
7.3
7
*
AA052, ,
NOMESCO Finland
+∞
7.3
7
*
G04BD08
ATC
solifenacin; oral
1.9
7.2
86
463
K11.72
ICD-10 Finland
Xerostomia
30.2
7.2
9
*
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
20.2
7.1
10
5
R13
ICD-10 Finland
Dysphagia
1.9
7.1
86
466
G04CB01
ATC
finasteride; oral
1.6
7.0
193
1315
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
7.0
145
921
H02AB02
ATC
dexamethasone; systemic
0.4
7.0
26
705
K56.2
ICD-10 Finland
Volvulus
4.4
7.0
17
39
H50.52
ICD-10 Finland
Exophoria
5.5
6.9
19
35
R1430, ,
SPAT
4.0
6.9
19
48
N03AX12
ATC
[U] gabapentin; oral
1.6
6.9
156
1015
R74
ICPC
Upper respiratory infection acute
0.5
6.9
58
1127
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
6.9
273
2016
N06AX21
ATC
duloxetine; oral
1.9
6.8
93
524
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
9.4
6.8
13
14
RF120, ,
NOMESCO Finland
4.3
6.8
17
40
WX212
NOMESCO Finland
Femoral plexus blockade
2.5
6.7
40
163
S01.3
ICD-10 Finland
Open wound of ear
3.8
6.7
20
54
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.4
6.6
25
673
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
2.4
6.4
43
185
103
Kela drug reimbursment
Diabetes, insulin-treated
0.6
6.4
178
2505
L12.0
ICD-10 Finland
Bullous pemphigoid
4.1
6.4
17
42
S01.8
ICD-10 Finland
Open wound of other parts of head
3.1
6.3
25
81
C10AA07
ATC
rosuvastatin; oral
0.6
6.3
158
2275
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.2
6.3
*
257
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
6.3
427
3472
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
+∞
6.3
6
*
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
3.1
6.2
25
82
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
3.7
6.2
19
52
R1100, ,
SPAT
3.7
6.2
19
52
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.6
6.1
79
1347
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
6.1
146
961
K86
ICPC
Hypertension uncomplicated
0.5
6.1
61
1123
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
4.2
6.1
16
39
D12
ICPC
Constipation
2.1
6.1
56
275
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.5
6.1
37
152
H50.31
ICD-10 Finland
Intermittent exotropia
8.7
6.1
12
14
F0029, G308,
ICD-10 Finland
10.1
6.0
11
11
R4120, ,
SPAT
3.5
6.0
20
58
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
175
3209
0.45
20.73
3.1
3.5
7.16
7.13
mmol/l
0.03
138
2645
350
2176
1.94
20.52
2.1
1.8
1081.70
1178.36
nmol/l
1.22
248
1626
195
3310
0.49
17.79
3.9
4.2
7.02
9.88
mg/mmol
0.77
125
2157
160
2907
0.46
17.73
1.6
1.9
1.07
1.25
mmol/l
4.10
133
2329
421
3015
1.69
14.05
2.9
2.3
298.16
249.42
u/l
0.44
398
2835
24
20
12.27
13.63
2.2
1.3
70.71
78.00
nmol/l
0.10
14
12
707
5860
1.72
13.03
7.8
5.6
4081.26
1896.73
e6/l
0.29
23
112
303
2019
1.72
12.99
2.2
1.9
—
—
—
0
0
113
577
2.08
11.01
1.4
1.5
—
—
—
0
0
231
1521
1.68
9.98
2.1
1.8
—
—
—
0
0
602
6974
0.65
9.34
4.1
5.4
1.41
1.41
mmol/l
0.01
516
6206
611
7046
0.65
9.13
4.1
5.5
4.19
4.24
mmol/l
0.57
526
6340
434
3366
1.51
9.12
2.7
2.2
—
—
—
0
0
575
6710
0.66
9.07
3.6
4.6
1.11
1.24
mmol/l
6.31
481
5887
214
1426
1.64
8.71
2.2
1.9
—
—
—
0
0
373
2869
1.48
7.84
4.1
3.7
0.54
0.53
e6/l
0.06
295
2217
406
3182
1.47
7.72
2.0
1.9
16.87
19.64
nmol/l
3.99
362
2647
538
4459
1.45
7.58
2.6
2.4
82.81
92.90
pmol/l
7.47
340
2424
641
7234
0.68
7.49
4.8
6.5
2.36
2.39
mmol/l
0.45
549
6476
62
1179
0.49
6.88
3.3
4.1
2.90
25.03
ug/l
2.48
46
1003
533
4461
1.42
6.81
6.0
4.6
10.28
3.33
estimate
0.29
145
1052
534
4482
1.41
6.65
6.0
4.6
0.03
0.31
estimate
0.45
141
979
294
2226
1.46
6.44
1.9
1.9
384.57
6573464.84
pmol/l
0.80
238
1780
296
2252
1.45
6.30
6.1
4.3
0.01
0.06
estimate
0.70
110
776
407
3280
1.41
6.29
6.3
4.8
0.03
0.06
estimate
0.52
117
849
521
4389
1.39
6.16
6.0
4.6
0.00
0.00
estimate
-0.00
140
1010
582
5026
1.38
5.75
5.6
7.5
1.21
1.21
mmol/l
1.11
482
4271
407
3320
1.38
5.70
4.3
3.8
44.62
114.28
e6/l
1.92
327
2635
49
240
2.10
5.39
1.5
1.3
—
—
—
0
0
49
240
2.10
5.39
1.5
1.3
—
—
—
0
0
174
2390
0.67
5.38
2.1
3.2
334.65
369.42
umol/l
3.40
136
2025
228
1699
1.44
5.31
3.7
3.5
2.39
1.92
e6/l
0.39
125
930
21
70
3.04
5.12
3.0
2.4
—
—
—
0
0
68
1144
0.56
5.00
1.2
1.3
68.83
36.79
iu/ml
0.53
25
367
644
7105
0.73
4.97
6.7
7.8
39.76
41.03
mmol/mol
3.30
562
6459
235
1801
1.40
4.62
3.7
3.3
1.05
1.10
e6/l
0.08
134
1032
353
2910
1.33
4.32
2.2
2.4
2.68
3.01
mg/l
2.14
278
2480
119
810
1.53
4.31
2.2
1.7
—
—
—
0
0
71
426
1.72
4.28
2.0
2.1
383.00
521.02
ug/l
0.38
66
403
67
1083
0.59
4.23
1.3
1.3
12.66
14.45
u/ml
0.08
24
343
643
7039
0.75
4.20
24.9
22.2
78.25
68.69
ml/min/173m2
34.33
601
6631
422
3578
1.31
4.20
5.1
4.4
130.15
133.66
e6/l
0.04
331
2682
39
195
2.04
4.13
1.3
1.3
574.29
600.12
mg/l
0.10
34
181
31
620
0.48
4.00
1.3
1.3
—
—
—
0
0
21
81
2.63
3.99
1.1
1.0
32.06
43.88
ng/l
0.98
16
49
36
671
0.52
3.76
1.4
1.5
—
—
—
0
0
452
3916
1.28
3.66
5.6
4.8
46.41
72.55
ng/l
0.81
386
3225
605
5439
1.29
3.64
5.2
5.5
6.39
6.95
mmol/l
15.66
585
5222
669
7238
0.77
3.63
5.0
6.0
6.01
6.18
mmol/l
3.19
562
6402
0
89
0.00
3.51
0.0
1.6
—
—
—
0
0
510
4528
1.26
3.24
4.9
6.8
1.20
1.21
mmol/l
0.58
461
4143
499
4420
1.26
3.23
3.7
5.2
33.88
34.10
g/l
0.36
446
4101
51
306
1.70
3.14
3.9
3.4
1.61
1.64
mmol/l
0.07
51
298
38
657
0.56
3.12
1.8
2.4
11.92
12.15
nmol/l
0.06
30
562
63
403
1.60
3.04
2.2
1.8
—
—
—
0
0
187
2337
0.75
3.04
2.8
3.7
0.76
0.81
ug/l
0.32
129
1712
116
849
1.41
2.95
2.8
4.0
1.22
1.22
mmol/l
0.08
95
720
241
1972
1.29
2.95
5.5
4.9
1.02
1.02
kg/l
1.86
171
1368
284
2385
1.27
2.81
3.3
2.9
4.99
4.30
e6/l
0.51
260
2186
308
2613
1.26
2.80
6.0
4.6
0.00
0.00
estimate
0.50
116
888
7
201
0.34
2.68
1.1
1.2
—
33.55
—
0
6
31
169
1.86
2.65
1.3
1.3
1.74
61.33
e6/l
1.02
23
133
31
170
1.85
2.61
1.2
1.2
3.72
3.84
mmol/l
0.34
26
158
11
273
0.40
2.56
1.1
1.4
—
—
—
0
0
107
793
1.39
2.55
1.6
2.1
409.19
391.26
nmol/l
0.39
84
722
31
172
1.83
2.52
1.6
1.3
226.84
995.94
e6/l
0.60
25
138
43
676
0.62
2.48
3.0
3.4
68.05
55.37
ml/min/173m2
1.02
20
304
7
193
0.36
2.41
1.1
1.2
—
2.87
—
0
22
0
66
0.00
2.41
0.0
2.4
—
65.40
—
0
15
8
22
3.66
2.36
2.6
2.4
—
—
—
0
0
6
169
0.35
2.29
1.2
1.1
—
2.53
—
0
12
26
454
0.56
2.27
2.5
2.8
—
—
—
0
0
0
61
0.00
2.24
0.0
1.0
—
—
—
0
0
19
93
2.06
2.22
3.0
2.3
0.89
1.67
u/field
—
9
45
141
1116
1.31
2.21
6.0
3.8
—
—
—
0
0
8
24
3.35
2.18
2.6
2.3
—
—
—
0
0
63
442
1.45
2.07
2.3
1.9
—
—
—
0
0
417
3747
1.19
2.03
2.3
2.4
71.83
79.92
nmol/l
8.07
344
3249
82
1079
0.74
1.89
3.5
5.4
37.15
33.19
%
1.46
40
668
26
429
0.60
1.88
2.2
3.2
108.36
9618.32
u/ml
0.85
21
367
37
237
1.58
1.87
1.5
2.6
23.67
33.59
umol/l
3.72
30
207
11
235
0.46
1.83
1.5
1.5
0.29
25.14
iu/ml
—
5
48
10
221
0.45
1.82
1.1
1.3
0.22
0.23
g/l
—
10
213
97
753
1.32
1.77
5.3
5.8
25.30
24.28
mmol/l
2.03
91
718
79
1034
0.74
1.77
3.2
6.5
10.15
11.89
mmol/l
1.67
70
987
9
36
2.51
1.74
1.0
1.2
—
—
—
0
0
11
227
0.48
1.68
1.1
1.3
1.15
1.14
g/l
0.04
11
217
12
56
2.16
1.61
1.1
1.1
—
—
—
0
0
54
389
1.41
1.59
4.9
4.5
25.64
24.88
mmol/l
1.21
45
354
10
204
0.49
1.50
1.1
1.3
—
—
—
0
0
777
7466
1.19
1.45
26.9
21.9
30.65
29.06
mg/l
0.66
726
6498
15
80
1.89
1.45
1.5
1.3
—
—
—
0
0
12
59
2.05
1.44
1.0
1.2
—
—
—
0
0
292
3248
0.86
1.43
4.2
5.2
20.73
21.82
%
0.67
145
1788
197
1705
1.19
1.42
1.7
3.0
0.83
0.82
mmol/l
0.89
178
1600
15
81
1.86
1.40
1.5
1.3
—
—
—
0
0
11
53
2.09
1.39
1.5
1.3
—
—
—
0
0
11
53
2.09
1.39
1.5
1.3
—
—
—
0
0
600
5664
1.15
1.37
3.9
4.1
15.52
15.23
pmol/l
1.76
518
5011
18
296
0.60
1.34
2.5
3.4
7.51
7.74
kpa
0.24
18
287
10
47
2.14
1.34
2.1
1.8
3.40
5.58
u/l
—
5
38
6
24
2.51
1.30
1.7
1.8
2.52
10.11
nmol/l
—
6
18
5
118
0.42
1.25
1.0
1.2
—
—
—
0
0
19
116
1.65
1.22
3.1
2.8
—
—
—
0
0
344
3745
0.88
1.21
3.2
3.5
1462.76
1989.55
ng/l
1.80
297
3325
23
148
1.57
1.21
1.4
1.5
2.37
3.50
iu/l
—
7
50
12
64
1.89
1.18
1.1
1.1
—
—
—
0
0
396
3662
1.14
1.17
2.6
3.2
159.91
160.75
ug/l
0.02
335
3300
14
236
0.59
1.17
1.2
1.5
33.08
30.42
g/l
0.33
14
211
15
248
0.60
1.17
1.2
1.5
—
—
—
0
0
0
33
0.00
1.16
0.0
2.1
—
787.67
—
0
6
0
36
0.00
1.14
0.0
1.4
—
—
—
0
0
742
7674
0.87
1.13
10.2
13.6
16.73
24.14
u/l
28.43
673
7377
8
40
2.01
1.12
1.0
1.1
—
—
—
0
0
119
1395
0.83
1.09
1.8
4.1
221.87
253.58
u/l
2.81
106
1319
52
403
1.31
1.04
1.3
1.3
—
—
—
0
0
18
114
1.59
1.03
1.6
1.5
—
—
—
0
0
18
114
1.59
1.03
1.6
1.5
—
—
—
0
0
159
1392
1.17
1.02
4.3
6.9
1.75
1.02
mmol/l
2.27
133
1116
9
47
1.92
1.02
2.1
2.3
—
—
—
0
0
7
35
2.01
1.00
1.0
1.1
—
64.00
%
—
0
5
120
1028
1.19
1.00
2.5
2.7
5.93
6.36
ug/l
0.13
64
903
18
115
1.58
1.00
1.6
1.5
—
—
—
0
0
18
270
0.66
0.96
1.2
1.5
—
—
—
0
0
18
117
1.55
0.94
1.6
1.4
—
—
—
0
0
18
118
1.54
0.91
1.6
1.4
—
—
—
0
0
31
415
0.74
0.89
2.3
3.3
25.43
24.90
mmol/l
0.34
31
405
134
1172
1.17
0.89
2.7
3.5
2.50
1.91
mmol/l
1.29
118
984
224
2033
1.13
0.88
4.5
4.6
148.95
332.36
ng/l
1.54
205
1837
523
4978
1.11
0.87
14.9
21.3
1.31
1.40
inr
2.96
452
4226
12
72
1.67
0.85
1.1
1.1
—
—
—
0
0
22
305
0.71
0.80
1.5
1.6
—
—
—
0
0
6
33
1.82
0.79
1.0
1.6
4.45
5.55
u/l
—
6
28
0
25
0.00
0.79
0.0
1.7
—
—
—
0
0
156
1398
1.14
0.76
4.3
6.9
5.08
5.07
kpa
0.07
149
1338
29
218
1.34
0.75
6.8
4.1
21.09
30.65
mg/l
1.41
24
153
156
1399
1.14
0.75
4.3
6.9
11.53
11.60
kpa
0.05
148
1340
17
116
1.47
0.74
1.6
1.4
—
—
—
0
0
100
869
1.17
0.74
2.8
2.6
0.65
0.67
e6/l
0.02
100
837
111
974
1.16
0.73
1.7
2.2
0.20
0.19
g/l
0.25
99
888
7
39
1.80
0.72
1.1
1.2
—
—
—
0
0
15
218
0.68
0.72
1.1
1.4
—
—
—
0
0
35
443
0.78
0.71
1.2
1.3
—
—
—
0
0
122
1081
1.15
0.71
10.0
9.3
—
—
—
0
0
15
216
0.69
0.69
1.5
2.0
8.89
13.67
mg/l
2.77
15
196
11
169
0.65
0.69
1.5
1.3
—
—
—
0
0
76
650
1.18
0.69
4.0
4.1
2.11
2.02
mmol/l
0.08
53
481
42
517
0.80
0.68
1.3
2.4
4.11
4.14
g/l
0.07
31
465
42
517
0.80
0.68
1.3
2.4
6.91
7.50
g/l
1.34
30
464
7
117
0.60
0.68
1.1
1.2
—
—
—
0
0
42
516
0.81
0.67
1.3
2.4
3.91
3.73
g/l
0.19
31
464
7
43
1.63
0.67
1.0
1.0
—
—
—
0
0
17
236
0.72
0.65
1.8
2.5
34.20
100.93
ug/min
—
8
140
39
480
0.80
0.64
1.3
2.4
3.14
3.04
g/l
0.19
27
428
131
1455
0.89
0.64
2.5
5.4
0.97
1.03
mmol/l
2.47
119
1351
20
266
0.75
0.60
1.3
1.5
—
—
—
0
0
0
21
0.00
0.60
0.0
1.2
—
27.66
—
0
11
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
13
89
1.47
0.58
1.6
1.4
—
54.44
—
0
9
18
132
1.37
0.57
1.3
1.3
—
—
—
0
0
94
833
1.14
0.57
1.9
1.6
—
—
—
0
0
10
149
0.67
0.57
1.1
1.1
—
—
—
0
0
19
141
1.35
0.56
1.0
1.1
—
6.46
—
0
5
8
55
1.46
0.56
1.1
1.5
—
—
—
0
0
8
123
0.65
0.55
1.3
1.2
9.13
13.45
u/l
—
8
111
8
123
0.65
0.55
1.5
3.8
—
—
—
0
0
19
250
0.76
0.54
1.0
1.1
—
—
—
0
0
14
99
1.42
0.54
2.1
1.5
—
—
—
0
0
47
555
0.84
0.53
1.6
1.6
1.50
1.74
%
2.66
38
437
10
66
1.52
0.52
1.1
1.5
—
—
—
0
0
24
304
0.78
0.52
1.1
1.1
71.14
130.99
u/ml
—
7
92
24
188
1.28
0.51
2.3
1.9
2.26
1.67
mmol/l
0.50
24
181
13
92
1.42
0.50
1.6
1.5
273.33
224.44
titre
—
6
9
190
1769
1.09
0.49
1.8
2.7
2.13
2.22
g/l
1.06
156
1624
601
5844
1.07
0.49
30.4
27.4
13.78
14.08
%
7.60
591
5753
300
2850
1.08
0.48
2.6
2.6
53.34
88.30
u/l
0.66
276
2627
32
263
1.22
0.47
2.1
3.7
3.07
1.66
index
0.51
15
137
38
450
0.84
0.46
1.3
3.6
45.87
108.77
mg/l
0.86
27
386
38
450
0.84
0.46
1.3
3.6
44.59
66.36
mg/l
0.79
28
383
73
820
0.88
0.46
2.6
3.8
78.04
100.28
ng/l
1.81
56
697
18
138
1.31
0.45
1.9
1.3
—
—
—
0
0
200
1875
1.08
0.45
1.8
2.7
11.29
11.72
umol/l
0.45
171
1739
14
186
0.75
0.44
1.1
1.4
—
—
—
0
0
62
548
1.14
0.42
1.9
1.8
1.37
2.84
ug/l
0.76
43
471
115
1055
1.10
0.42
2.9
3.3
198.43
256.66
ng/l
0.82
106
969
38
444
0.85
0.41
1.4
2.6
0.91
1.46
g/l
0.36
28
376
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
12.3
—
5.58
—
0
15
8
59
1.36
0.41
1.1
1.5
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
135
1251
1.09
0.40
4.3
7.2
95.80
95.14
%
0.92
129
1204
39
453
0.86
0.40
1.3
2.5
9.10
11.05
g/l
3.70
27
398
7
104
0.67
0.39
1.3
1.4
11.29
13.80
u/l
—
7
96
700
6868
1.07
0.39
5.3
5.3
1.93
2.09
mu/l
2.97
610
6138
14
106
1.33
0.39
2.1
1.5
25.88
25.53
u/ml
—
8
15
55
621
0.88
0.39
1.6
1.9
1.42
1.55
g/l
0.64
45
551
658
6445
1.06
0.39
5.7
8.7
82.90
83.11
u/l
0.03
595
6071
15
192
0.78
0.38
1.1
1.4
—
—
—
0
0
14
107
1.31
0.37
1.6
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
31
362
0.85
0.35
1.4
2.5
0.00
0.00
g/l
-0.00
23
314
95
1030
0.91
0.34
1.5
2.8
65.68
65.83
g/l
0.07
75
933
6
45
1.34
0.33
1.0
1.5
0.14
0.96
promille
—
6
34
6
45
1.34
0.33
1.0
1.1
—
—
—
0
0
237
2263
1.06
0.33
3.7
4.5
78.82
80.99
%
0.72
232
2219
6
90
0.66
0.33
1.2
1.6
—
—
—
0
0
6
90
0.66
0.33
1.2
1.6
—
—
—
0
0
6
90
0.66
0.33
1.2
1.6
—
—
—
0
0
29
338
0.85
0.32
1.4
2.5
0.00
0.00
g/l
-0.00
23
313
186
1765
1.07
0.32
1.7
1.7
1.56
1.68
mg/l
0.17
148
1406
27
314
0.86
0.30
1.7
1.6
—
—
—
0
0
392
4032
0.95
0.29
4.5
6.5
2.88
5.05
ug/l
1.21
326
3556
15
184
0.81
0.28
1.5
1.6
—
—
—
0
0
576
5650
1.05
0.28
31.2
29.6
330.42
330.66
g/l
0.25
562
5610
12
94
1.28
0.28
2.3
3.5
19.83
11.88
index
—
6
48
33
375
0.88
0.28
1.4
2.5
0.00
0.02
g/l
1.44
25
332
10
128
0.78
0.27
1.1
1.1
—
—
—
0
0
110
1034
1.07
0.26
1.8
2.9
9.58
10.08
umol/l
0.09
95
916
463
4732
0.96
0.25
6.4
9.0
4.71
4.43
e9/l
1.33
395
4077
411
4016
1.04
0.23
2.7
3.0
—
—
estimate
—
0
0
37
410
0.90
0.22
1.2
3.4
2.00
3.53
ratio
0.69
22
241
7
91
0.77
0.22
1.0
1.1
—
48.01
—
0
16
5
41
1.22
0.22
1.2
1.7
—
—
—
0
0
5
41
1.22
0.22
1.2
1.7
—
—
—
0
0
5
42
1.19
0.21
1.6
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
2.4
—
37.00
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
225
2176
1.04
0.21
2.6
3.2
2.46
2.47
mmol/l
0.65
195
1944
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
5257.00
—
0
7
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
5
43
1.16
0.21
1.6
2.9
9.58
9.97
kpa
—
5
43
5
43
1.16
0.21
1.6
2.9
4.65
4.83
kpa
—
5
43
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
26
230
1.13
0.20
1.6
1.6
33.94
28.39
u/ml
—
7
37
173
1664
1.05
0.20
1.9
2.7
21.57
21.55
%
0.01
145
1545
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
11
90
1.22
0.19
1.3
1.5
—
—
—
0
0
251
2576
0.97
0.17
2.2
3.1
36.85
36.06
u/l
0.04
229
2427
221
2271
0.97
0.16
2.3
2.6
—
—
—
0
0
25
277
0.90
0.16
1.3
1.3
—
—
—
0
0
11
130
0.84
0.16
1.2
1.2
—
—
—
0
0
27
245
1.10
0.15
2.6
2.7
15.20
15.68
%
0.40
27
239
39
361
1.08
0.15
2.4
3.0
4.33
4.21
pmol/l
0.44
31
311
28
255
1.10
0.15
1.4
1.5
23405.11
17524.84
e6/l
0.16
19
177
9
83
1.09
0.14
1.9
1.6
291.22
310.41
mu/l
—
9
75
8
99
0.81
0.13
1.1
1.8
—
—
—
0
0
13
148
0.88
0.12
1.2
1.1
—
19.14
—
0
7
141
1451
0.97
0.12
1.2
1.2
0.62
1.28
u/ml
2.72
32
347
79
758
1.05
0.12
4.3
4.1
5.21
5.16
kpa
0.18
70
723
14
157
0.89
0.11
1.1
1.5
—
—
—
0
0
169
1650
1.03
0.11
2.0
2.0
29.73
29.98
s
0.22
160
1597
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
7
64
1.09
0.08
1.0
1.1
108.14
110.00
%
—
7
56
7
66
1.06
0.08
3.1
2.7
30.00
30.44
mg/l
—
7
48
23
215
1.07
0.07
1.1
1.2
—
—
—
0
0
485
4813
1.02
0.07
3.8
6.7
12.17
12.86
umol/l
0.78
448
4589
23
216
1.07
0.07
1.1
1.2
—
—
—
0
0
8
94
0.85
0.06
1.1
1.8
—
—
—
0
0
28
266
1.05
0.06
1.4
1.4
—
—
—
0
0
29
276
1.05
0.06
1.4
1.4
307.00
264.45
ug/g
0.41
18
171
339
3361
1.01
0.06
2.3
3.4
2.33
2.35
mmol/l
0.88
299
3001
12
131
0.92
0.05
1.4
1.5
—
—
—
0
0
781
7835
0.98
0.05
32.1
29.9
73.82
89.26
umol/l
59.98
765
7708
783
7852
0.99
0.04
36.8
33.2
126.71
130.52
g/l
12.01
764
7721
783
7851
0.99
0.04
36.4
32.9
4.20
4.32
e12/l
9.94
756
7615
783
7851
0.99
0.04
36.8
33.6
37.92
38.99
%
6.06
764
7715
783
7851
0.99
0.04
36.5
32.9
232.45
233.61
e9/l
0.20
757
7648
783
7850
0.99
0.04
36.4
32.8
92.33
92.11
fl
0.69
764
7719
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
42
431
0.97
0.03
1.7
2.4
0.46
0.36
iu/ml
0.51
22
233
87
858
1.02
0.02
2.2
2.4
30.72
37.84
u/l
1.20
68
713
781
7798
1.01
0.02
31.1
27.4
139.81
139.48
mmol/l
2.70
764
7630
445
4441
1.00
0.01
3.3
3.4
53.38
60.44
u/l
0.43
402
4042
42
424
0.99
0.00
2.3
2.6
—
15.63
—
0
26
781
7805
1.00
0.00
31.1
27.6
3.96
4.03
mmol/l
10.26
763
7625
13
133
0.98
0.00
1.2
1.6
—
—
—
0
0
20
199
1.01
0.00
1.4
1.5
—
—
—
0
0
601
6009
1.00
0.00
3.8
4.6
12.54
15.94
mm/h
7.30
533
5503
24
245
0.98
0.00
1.1
1.3
—
—
—
0
0
6
66
0.91
0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
78.00
—
0
6
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
79
0.89
0.00
1.3
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
5.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.4
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.4
—
74.80
—
0
5
0
5
0.00
-0.00
0.0
1.6
—
2.60
—
0
5
5
54
0.93
-0.00
1.2
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.4
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
1.2
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
5
54
0.93
-0.00
1.2
1.6
—
—
—
0
0
5
57
0.88
-0.00
1.0
1.1
—
3.08
—
0
13
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
1.2
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
23.70
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PD_DEMENTIA – Dementia due to Parkinson's disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).